Comparison of the antihypertensive effects of the new angiotensin II (AT1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats. [electronic resource]
Producer: 20000921Description: 75-81 p. digitalISSN:- 0916-9636
- Administration, Oral
- Angiotensin I -- pharmacology
- Angiotensin II -- pharmacology
- Angiotensin III -- pharmacology
- Angiotensin Receptor Antagonists
- Angiotensin-Converting Enzyme Inhibitors -- pharmacology
- Animals
- Antihypertensive Agents -- pharmacology
- Benzimidazoles -- pharmacology
- Biphenyl Compounds -- pharmacology
- Blood Pressure -- drug effects
- Bradykinin -- pharmacology
- Enalapril -- pharmacology
- Enzyme Activation -- drug effects
- Hypertension, Renal -- drug therapy
- Male
- Peptidyl-Dipeptidase A -- blood
- Rats
- Rats, Inbred SHR
- Rats, Sprague-Dawley
- Rats, Wistar
- Receptor, Angiotensin, Type 1
- Receptor, Angiotensin, Type 2
- Renal Artery -- surgery
- Surgical Instruments
- Tetrazoles -- pharmacology
- Vasoconstrictor Agents -- pharmacology
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.